Home ›
Trademark Categories ›
Pharmaceuticals ›
2012 ›
CU ›
CURCUMIN FLUID
Trademark search for:
CURCUMIN FLUID
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2012-03-14 — Application filed
2012-06-14 — Sn assigned for sect 66a appl from ib
2012-06-15 — Application filed
2012-06-19 — Application filed
2012-06-21 — Final disposition recorded
2012-06-21 — Assigned to examiner
2012-06-22 — Office action issued
2012-06-22 — Office action issued
2012-07-16 — Final disposition recorded
2012-07-17 — Office action issued
2012-07-17 — Office action issued
2012-07-17 — Office action issued
2012-08-04 — Office action issued
2012-12-15 — Office action issued
2012-12-15 — Correspondence received in law office
2012-12-17 — Final disposition recorded
2012-12-17 — Teas/email correspondence entered
2012-12-17 — Final disposition recorded
2012-12-17 — Final disposition recorded
2013-02-13 — Examiners amendment -written
2013-02-13 — Approved for pub - principal register
2013-02-13 — Examiners amendment e-mailed
2013-02-13 — Notification of examiners amendment e-mailed
2013-02-13 — Examiner's amendment entered
2013-02-24 — Assigned to lie
2013-03-01 — Examiners amendment -written
2013-03-01 — Approved for pub - principal register
2013-03-01 — Examiners amendment e-mailed
2013-03-01 — Notification of examiners amendment e-mailed
2013-03-01 — Examiner's amendment entered
2013-03-01 — Previous allowance count withdrawn
2013-03-04 — Law office publication review completed
2013-03-17 — Withdrawn from pub - og review query
2013-04-01 — Previous allowance count withdrawn
2013-04-17 — Examiners amendment -written
2013-04-17 — Approved for pub - principal register
2013-04-17 — Examiners amendment e-mailed
2013-04-17 — Notification of examiners amendment e-mailed
2013-04-17 — Examiner's amendment entered
2013-04-20 — Law office publication review completed
2013-05-08 — Notification of possible opposition sent to ib
2013-05-08 — Notification of notice of publication e-mailed
2013-05-08 — Notice of start of opposition period created, to be sent to ib
2013-05-28 — Published for opposition
2013-05-28 — Official gazette publication confirmation e-mailed
2013-07-21 — Notification processed by ib
2013-08-13 — Registered-principal register
2013-11-13 — Final disposition recorded
2013-11-13 — Final disposition recorded
2013-11-13 — Final disposition recorded
2013-12-02 — Final disposition recorded
2014-09-18 — New representative at ib received
2018-08-13 — Courtesy reminder - sec. 71 (6-yr) e-mailed
2021-02-26 — Cancelled section 71
2021-10-26 — Total invalidation of reg ext protection created
2021-12-22 — Total invalidation of reg ext protection sent to ib
2021-12-22 — Invalidation processed
2022-01-22 — Total invalidation processed by the ib
2022-03-14 — Final status recorded
2022-10-09 — Death of international registration
2022-10-09 — Notification of effect of cancellation of intl reg e-mailed
Owner Information
Orphanidis Pharma Research GmbH
AT
Orphanidis Pharma Research GmbH
AT
Orphanidis Pharma Research GmbH
AT
Correspondent
Michael Fedrick Loza & Loza, LLP 305 N. Second Ave. #127 Upland, CA 91786-6064 UNITED STATES
Filing Details
Filing Date:
2012-03-14
Status Date:
2022-03-14
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.